Zang Fu theory Clinical Trials

• Randomized Phase III Study of 5-FU Versus MTX+5-FU in Gastric Cancer with Peritoneal Metastasis (JCOG0106-MF, MF/5FU)
  ClinicalTrials.gov Identifier: NCT00149201 - Active, not recruiting
  Gastric Cancer with Peritoneal Metastasis
  
• Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00337389 - Active, not recruiting
  Metastatic Colorectal Cancer; Colon Cancer; Rectal Cancer
  
• Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00143403 - Recruiting
  Colorectal Neoplasms; Neoplasm Metastasis - Hepatic
  
• Phase III Study of Cetuximab, Oxaliplatin, 5-FU/LV vs. Oxaliplatin, 5-FU/LV in Patients with Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00061815 - Active, not recruiting
  Colorectal Cancer
  
• The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR
  ClinicalTrials.gov Identifier: NCT00371020 - Active, not recruiting
  Proliferative Vitreoretinopathy
  
• Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00290966 - Completed
  Stomach Neoplasm
  
• LT FU Studies at Y6,7 8,9,10: 2 Formulations of Combined hepatitisA/B Vaccine Compared in Subjects Aged 12-15 y
  ClinicalTrials.gov Identifier: NCT00197119 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-Line Treatment)
  ClinicalTrials.gov Identifier: NCT00289445 - Active, not recruiting
  Gastrointestinal Neoplasms; Neoplasm Metastasis
  
• Oxaliplatin and 5-FU Based Preoperative Chemoradiation
  ClinicalTrials.gov Identifier: NCT00278694 - Recruiting
  Rectal Cancer
  
• A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)
  ClinicalTrials.gov Identifier: NCT00190515 - Active, not recruiting
  Colorectal Neoplasms
  
• Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00291785 - Active, not recruiting
  Colorectal Cancer
  
• Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00413322 - Recruiting
  Tumor
  
• Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00286819 - Completed
  Breast Cancer
  
• Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of PVR
  ClinicalTrials.gov Identifier: NCT00370760 - Recruiting
  Proliferative Vitreoretinopathy
  
• Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00168155 - Active, not recruiting
  Colorectal Adenocarcinoma; Liver Metastases
  
• Safety/Efficacy of Camptosar, Avastin, & 5-FU/LV 2-Schedules w/ Celebrex/Placebo as Colorectal Cancer Initial Treatment
  ClinicalTrials.gov Identifier: NCT00101686 - Active, not recruiting
  Colorectal Cancer; Metastases
  
• Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen
  ClinicalTrials.gov Identifier: NCT00417209 - Recruiting
  Pancreatic Neoplasms
  
• Study of TNFerade™ gene therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00051480 - Active, not recruiting
  Esophageal Cancer
  
• GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
  ClinicalTrials.gov Identifier: NCT00044343 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in theTreatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
  ClinicalTrials.gov Identifier: NCT00561470 - Recruiting
  Colorectal Neoplasms; Neoplasm Metastasis
  
• Low-Dose CDGP/5-FU Combined With Radiation for Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00197444 - Recruiting
  Esophageal Cancer; Squamous Cell Carcinoma
  
• Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00559455 - Recruiting
  Carcinoma, Hepatocellular
  
• Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-Treated Pts With Metastatic Esophageal Cancer.
  ClinicalTrials.gov Identifier: NCT00209716 - Recruiting
  Esophageal Cancer
  
• Oxaliplatin + 5-FluoroUracil/LeucoVorin(5-FU/LV) (FOLFOX4) vs Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients
  ClinicalTrials.gov Identifier: NCT00471965 - Recruiting
  Carcinoma, Hepatocellular
  
• A New Agent DAVANAT in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00388700 - Recruiting
  Colorectal Cancer
  
• FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00501410 - Recruiting
  Colorectal Cancer
  
• Genetic Risk Factors for Lung Cancer in Non-Smoking Women in Xuan Wei and Fu Yuan Counties in Yun Nan Province, China
  ClinicalTrials.gov Identifier: NCT00341926 - Recruiting
  Lung Cancer
  
• A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00524498 - Recruiting
  Hepatocellular Carcinoma
  
• A Theory Based HIV Prevention Video For Rapid HIV Testing: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00250549 - Active, not recruiting
  Rapid HIV Testing
  
• Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients
  ClinicalTrials.gov Identifier: NCT00447967 - Recruiting
  Gastric Cancer
  
• Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00422773 - Recruiting
  Metastatic Colorectal Cancer
  
• First-line treatment of metastatic colorectal cancer with oxaliplatin/5-FU/leucovorin plus PTK787/ZK 222584 or placebo
  ClinicalTrials.gov Identifier: NCT00056459 - Active, not recruiting
  Colorectal Neoplasms; Colonic Neoplasms; Rectal Neoplasms
  
• Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00307723 - Recruiting
  Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma
  
• Study to Test the Benefit and Safety of DAVANAT in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00386516 - Recruiting
  Cancer of the Bile Duct; Gallbladder Cancer
  
• Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00284258 - Recruiting
  Colorectal Cancer
  
• Study of TNFerade™ Biologic with 5-FU and Radiation Therapy for the Treatment of Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00051467 - Recruiting
  Pancreatic Cancer
  
• Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00202969 - Recruiting
  Gastric Cancer
  
• TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
  ClinicalTrials.gov Identifier: NCT00540397 - Recruiting
  Liver Cirrhosis
  
• Treatment of Peritoneal Cancer with Surgery, Perfused Heated Cisplatin and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004547 - Recruiting
  Abdominal Neoplasm; Colonic Neoplasm; Mesothelioma; Peritoneal Neoplasm
  
• XENOX – Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
  ClinicalTrials.gov Identifier: NCT00272051 - Completed
  Metastases; Colorectal Neoplasms; Colorectal Carcinoma
  
• Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract
  ClinicalTrials.gov Identifier: NCT00201305 - Completed
  Biliary Tract Disease
  
• Safety and Efficacy Study of XELOX Vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00202774 - Completed
  Colorectal Cancer
  
• Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00209625 - Completed
  Colorectal Cancer
  
• Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
  ClinicalTrials.gov Identifier: NCT00140036 - Completed
  Colorectal Neoplasms
  
• Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00154700 - Completed
  Esophageal Cancer
  
• Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00205322 - Completed
  Metastatic Colorectal Cancer
  
• Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00260026 - Completed
  Non-Small Cell Lung Cancer
  
• Investigational Drug in Patients with Metastatic Colorectal Cancer who Failed Treatment with a 5-FU/Leucovorin Regimen
  ClinicalTrials.gov Identifier: NCT00078468 - Completed
  Colorectal Neoplasms
  
• Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis
  ClinicalTrials.gov Identifier: NCT00001569 - Completed
  Carcinoma; Peritoneal Neoplasm
  
• Local and Systemic Chemotherapy with or without Isolated Liver Perfusion for Patients with Inoperable Metastatic Colorectal Cancers of the Liver
  ClinicalTrials.gov Identifier: NCT00011427 - Completed
  Colorectal Cancer
  
• Study of Oxaliplatin, 5-FU, Leucovorin and Cetuximab in Colon Cancer Patients Who Have Undergone Surgery
  ClinicalTrials.gov Identifier: NCT00170092 - Suspended
  Stage III Colon Cancer
  
• Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00154791 - Completed
  Pancreatic Adenocarcinoma
  
• A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
  ClinicalTrials.gov Identifier: NCT00000758 - Completed
  HIV Infections; Cervix, Dysplasia
  
• OSI-7904L versus 5-Fluorouracil/Leucovorin (5-FU/LV) as Treatment in Patients with Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00088270 - Completed
  Bilary Tract Cancer
  
• Theory-based Interventions for Smoking and Obesity (Challenge) Trial
  ClinicalTrials.gov Identifier: NCT00040287 - Completed
  Smoking; Obesity
  
• Tezacitabine with or without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00054873 - Completed
  Esophageal Neoplasms; Stomach Neoplasms; Adenocarcinoma
  
• Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
  ClinicalTrials.gov Identifier: NCT00162708 - Completed
  Oropharynx Cancer; Oral Cancer; Hypopharynx Cancer; Larynx Cancer
  
• Effect Study of a Theory-Based Internet Intervention on Safe-Sex Practices
  ClinicalTrials.gov Identifier: NCT00378885 - Terminated
  Sexual Risk Behavior for HIV-Infection
  
• XL119 Versus 5-Fluorouracil (5-FU) plus Leucovorin (LV) in Subjects with Advanced Biliary Tumors
  ClinicalTrials.gov Identifier: NCT00090025 - Terminated
  Biliary Tract Cancer
  
• Irinotecan in Combination with 5-FU, Leucovorin (FOLFIRI) Plus Bevacizumab in Patients with Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00106054 - Terminated
  Colorectal Cancer; Neoplasm Metastasis; Liver Cancer